Back to trial detailsIntake questionnaire
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Applying to Agile Clinical Research Trials, LLC · Atlanta, Georgia
Answer a few short questions to share with the research team.
0 of 4 answered